Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07213154 · ClinicalTrials.gov registry record · NA
Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions
A NA study of Skin Neoplasm and Malignant Skin Neoplasm, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT07213154 is a NA study of Skin Neoplasm and Malignant Skin Neoplasm that is actively recruiting participants, run by Emory University. The registered enrollment target is 10 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT07213154, a NA study of Skin Neoplasm and Malignant Skin Neoplasm, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a non-invasive procedure that uses red light for illumination, and may work better than no imaging procedures in aiding doctors in diagnosing skin lesions.
Conditions Studied
Interventions
- RADIATION Radiation Therapy
- PROCEDURE Quantitative Oblique Back-Illumination Microscopy
Study Locations (2)
Georgia
- Emory University Hospital Midtown - Atlanta
- Emory University Hospital/Winship Cancer Institute - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-10-15 |
| Est. Completion | 2027-09-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07213154
The ClinicalTrials.gov registry entry for NCT07213154 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Skin Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Radiation Therapy is the first listed.
NCT07213154 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT07213154 about?
NCT07213154 is a clinical study titled "Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions". This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a non-invasive procedure that uses red light for illumination, and may work better than no imaging proce...
What is the current status of trial NCT07213154?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-10-15. Estimated completion is 2027-09-17.
What conditions does trial NCT07213154 study?
This clinical trial studies the following conditions: Skin Neoplasm, Malignant Skin Neoplasm, Skin Disorder.
What interventions are being tested in trial NCT07213154?
The interventions under investigation include: Radiation Therapy (RADIATION), Quantitative Oblique Back-Illumination Microscopy (PROCEDURE).
Who is sponsoring clinical trial NCT07213154?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07213154 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.